These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1311442)

  • 1. [Non surgical treatments of hepatocellular carcinoma].
    Roche A
    Pathol Biol (Paris); 1992 Nov; 39(9):900-1. PubMed ID: 1311442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
    Trinchet JC; Mathieu D; Beaugrand M
    Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent advances of non-surgical treatment of hepatocellular carcinoma].
    Harada T
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1244-9. PubMed ID: 2175340
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel intraarterial therapy for liver cancer using ethylbromopyruvate dissolved in an iodized oil.
    Choi YH; Chung JW; Son KR; So YH; Kim W; Yoon CJ; Yoon JH; Chung H; Kim HC; Jae HJ; Kim YI; Park JH
    Acad Radiol; 2011 Apr; 18(4):471-8. PubMed ID: 21237678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Large amount of intra-arterial injection of iodized oil (Lipiodol) in the treatment of unresectable hepatoma].
    Onodera H; Oikawa M; Abe M; Chida N; Kimura S; Goto Y
    Rinsho Hoshasen; 1986 Feb; 31(2):269-73. PubMed ID: 3012157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transcatheter oily chemoemobolization of hepatocellular carcinoma using adriamycin, lipiodol and gelfoam: pharmacokinetics of adriamycin].
    Nakamura H; Hashimoto T; Taguchi T; Inoue K; Oi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):623-5. PubMed ID: 3006598
    [No Abstract]   [Full Text] [Related]  

  • 7. [TAE therapy of hepatocellular carcinoma].
    Kudo M
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2012-8. PubMed ID: 8586923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
    Inoue H; Kobayashi H; Kajiya Y; Hidaka H; Ikeda K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):620-2. PubMed ID: 3006597
    [No Abstract]   [Full Text] [Related]  

  • 9. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Koizumi J
    Cardiovasc Intervent Radiol; 2006; 29(5):928; author reply 929. PubMed ID: 16502170
    [No Abstract]   [Full Text] [Related]  

  • 10. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
    Novell JR; Hilson AJ
    J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
    [No Abstract]   [Full Text] [Related]  

  • 11. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
    Ichida T; Van Thiel DH; Hassanein T
    Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
    Tanikawa K
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
    Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum U; Spangenberg HC; Moser E; Blum HE
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1984-94. PubMed ID: 8984607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Portal vein embolization for hepatoma with lipiodol-fibrin adhesive mixture].
    Matsuoka T; Nakatsuka H; Kobayashi N; Yamada T; Nakamura K; Tamaoka K; Minakuchi K; Onoyama Y; Kinoshita H; Hirohashi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Nov; 44(11):1411-3. PubMed ID: 6085152
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow-up.
    Nakao N; Kamino K; Miura K; Takayasu Y; Ohnishi M; Miura T
    Radiat Med; 1992; 10(1):13-8. PubMed ID: 1316626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of unresectable hepatocellular carcinoma.
    Vauthey JN; Marsh RW; Davis GL
    N Engl J Med; 1995 Sep; 333(13):877; author reply 878. PubMed ID: 7651489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatocellular carcinoma complicating cirrhosis. Therapeutic possibilities].
    Porcheron J; Cadi F; Tardieu D; Balique JG
    Ann Gastroenterol Hepatol (Paris); 1992; 28(3):131-9. PubMed ID: 1325136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.